{"pmid":32366726,"title":"Management of Asthma in Children during COVID-19 Pandemic.","text":["Management of Asthma in Children during COVID-19 Pandemic.","Indian Pediatr","Kumar, Prawin","Goyal, Jagdish P","32366726"],"journal":"Indian Pediatr","authors":["Kumar, Prawin","Goyal, Jagdish P"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366726","source":"PubMed","week":"202019|May 04 - May 10","topics":["Prevention"],"weight":1,"_version_":1666138496210829312,"score":9.490897,"similar":[{"pmid":32330469,"pmcid":"PMC7172836","title":"Managing Asthma during COVID-19: An Example for Other Chronic Conditions in Children and Adolescents.","text":["Managing Asthma during COVID-19: An Example for Other Chronic Conditions in Children and Adolescents.","J Pediatr","Abrams, Elissa M","Szefler, Stanley J","32330469"],"journal":"J Pediatr","authors":["Abrams, Elissa M","Szefler, Stanley J"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330469","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jpeds.2020.04.049","topics":["Prevention"],"weight":1,"_version_":1666138494702977024,"score":46.898064},{"pmid":32418233,"title":"Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares?","text":["Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares?","Coronavirus disease 2019 (COVID-19) pandemic is affecting people at any age with a more severe course in patients with chronic diseases or comorbidities, males and elderly patients. The Center for Disease Control and Prevention (CDC) initially proposed that patients with chronic lung diseases, including moderate-severe asthma, and allergy may have a higher risk of developing severe COVID-19 than otherwise healthy people (https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/asthma.html).","Allergy","Licari, Amelia","Votto, Martina","Brambilla, Ilaria","Castagnoli, Riccardo","Piccotti, Emanuela","Olcese, Roberta","Tosca, Maria Angela","Ciprandi, Giorgio","Luigi Marseglia, Gian","32418233"],"abstract":["Coronavirus disease 2019 (COVID-19) pandemic is affecting people at any age with a more severe course in patients with chronic diseases or comorbidities, males and elderly patients. The Center for Disease Control and Prevention (CDC) initially proposed that patients with chronic lung diseases, including moderate-severe asthma, and allergy may have a higher risk of developing severe COVID-19 than otherwise healthy people (https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/asthma.html)."],"journal":"Allergy","authors":["Licari, Amelia","Votto, Martina","Brambilla, Ilaria","Castagnoli, Riccardo","Piccotti, Emanuela","Olcese, Roberta","Tosca, Maria Angela","Ciprandi, Giorgio","Luigi Marseglia, Gian"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32418233","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/all.14369","keywords":["allergy","covid-19","sars-cov2 infection","adolescents","asthma","children"],"topics":["Prevention"],"weight":1,"_version_":1667058206763909121,"score":45.24548},{"pmid":32374540,"title":"[Asthma and COPD management during the COVID-19 pandemic].","text":["[Asthma and COPD management during the COVID-19 pandemic].","Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.","Rev Med Suisse","Daccord, Cecile","Touilloux, Brice","Von Garnier, Christophe","32374540"],"abstract":["Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease."],"journal":"Rev Med Suisse","authors":["Daccord, Cecile","Touilloux, Brice","Von Garnier, Christophe"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374540","source":"PubMed","week":"202019|May 04 - May 10","topics":["Prevention"],"weight":1,"_version_":1666138496331415553,"score":44.58227},{"pmid":32332038,"title":"Asthma and COVID-19.","text":["Asthma and COVID-19.","CMAJ","Abrams, Elissa M","Geert W, 't Jong","Yang, Connie L","32332038"],"journal":"CMAJ","authors":["Abrams, Elissa M","Geert W, 't Jong","Yang, Connie L"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32332038","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1503/cmaj.200617","topics":["Prevention"],"weight":1,"_version_":1666138493934370816,"score":40.470867},{"pmid":32358994,"title":"Asthma and COVID-19: is asthma a risk factor for severe outcomes?","text":["Asthma and COVID-19: is asthma a risk factor for severe outcomes?","When I first read the manuscript that accompanies this editorial, upon its online publication on February 19(th) 2020(1), COVID-19 had already killed 2118 people in China, but only one person in Europe - an 80-year-old tourist from China, who died in France on the 15(th) February. I read the manuscript with grim fascination, as it was clear that SARS-CoV-2 had spread very rapidly in China which already had 74,576 cases and in South Korea which already had 58 cases, and that it was then invading Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countries too.","Allergy","Johnston, Sebastian L","32358994"],"abstract":["When I first read the manuscript that accompanies this editorial, upon its online publication on February 19(th) 2020(1), COVID-19 had already killed 2118 people in China, but only one person in Europe - an 80-year-old tourist from China, who died in France on the 15(th) February. I read the manuscript with grim fascination, as it was clear that SARS-CoV-2 had spread very rapidly in China which already had 74,576 cases and in South Korea which already had 58 cases, and that it was then invading Europe also, as France already had 12 cases, Germany 16, the UK 9, Italy 3, Spain 2 and other countries too."],"journal":"Allergy","authors":["Johnston, Sebastian L"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358994","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/all.14348","keywords":["covid-19","asthma"],"locations":["China","China","France","China","South Korea","France","Germany","GBR","Italy","Spain"],"countries":["Germany","Korea, Republic of","Spain","United Kingdom","China","Italy","France"],"countries_codes":["DEU|Germany","KOR|Korea, Republic of","ESP|Spain","GBR|United Kingdom","CHN|China","ITA|Italy","FRA|France"],"topics":["Treatment","Prevention","Diagnosis"],"weight":1,"_version_":1666138495304859649,"score":40.295998}]}